000 01102 a2200337 4500
005 20250511184545.0
264 0 _c19930106
008 199301s 0 0 eng d
022 _a0006-8993
024 7 _a10.1016/0006-8993(92)91326-a
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAltemus, M
245 0 0 _aChronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro.
_h[electronic resource]
260 _bBrain research
_cOct 1992
300 _a311-3 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aArginine Vasopressin
_xmetabolism
650 0 4 _aDesipramine
_xpharmacology
650 0 4 _aFluoxetine
_xpharmacology
650 0 4 _aHypothalamus
_xdrug effects
650 0 4 _aMale
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReference Values
650 0 4 _aTrazodone
_xpharmacology
700 1 _aCizza, G
700 1 _aGold, P W
773 0 _tBrain research
_gvol. 593
_gno. 2
_gp. 311-3
856 4 0 _uhttps://doi.org/10.1016/0006-8993(92)91326-a
_zAvailable from publisher's website
999 _c1457427
_d1457427